Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Compound and composition as well as application thereof to drugs preparation

A technology of compounds and compositions, applied in the field of novel antagonist compounds, capable of solving problems such as insignificant ability of prostate cancer cells

Active Publication Date: 2018-12-11
CHANGSHA ZEDA MEDICAL TECH CO LTD
View PDF2 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the ability of the above-mentioned drugs to directly kill prostate cancer cells is not significant. In cell biology experiments, their IC50 is above 10uM

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compound and composition as well as application thereof to drugs preparation
  • Compound and composition as well as application thereof to drugs preparation
  • Compound and composition as well as application thereof to drugs preparation

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0036] Compounds of the present invention have the structure of formula I:

[0037]

[0038] Wherein, R1 is selected from hydrogen, fluorine, chlorine; R2 and R3 are independently selected from hydrogen, alkyl, substituted alkyl, alkenyl or substituted alkenyl, alkynyl or substituted alkynyl, aryl, R2 and R3 can be connected to form a ring which can be cycloalkyl, substituted cycloalkyl, aromatic heterocycle or non-aromatic heterocycle; R4 is selected from hydrogen, cyano, alkyl, substituted alkyl, alkenes Base or substituted alkenyl, alkynyl or substituted alkynyl, aryl; R5 is selected from hydrogen, halogen, haloalkyl.

[0039] The term "alkyl" as used herein denotes a branched or straight hydrocarbon chain, preferably having from about 1 to about 5 carbons, such as methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl , Isobutyl, tert-butyl, 2-methylpentyl, pentyl, etc. "Substituted alkyl" means that the aforementioned alkyl is replaced by one or more functional group...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to a compound having a structure of formula I or a pharmaceutically acceptable salt of the compound. Regarding the compound, R1 is selected from hydrogen, fluorine, and chlorine; R2 and R3 are independently selected from hydrogen, alkyl, substituted alkyl, alkenyl or substituted alkenyl, alkynyl or substituted alkynyl, and aryl, wherein R2 and R3 can be bonded to forma ring, and the ring can be cycloalkyl, substituted cycloalkyl, an aromatic heterocyclic ring or a non-aromatic heterocyclic ring; R4 is selected from hydrogen, cyano, alkyl, substituted alkyl, alkene or substituted alkenyl, alkynyl or substituted alkynyl, and aryl; R5 is selected from hydrogen, halogen, and haloalkyl. The invention further relates to a pharmaceutical composition comprising the compound. The compound and composition provided by the invention shows significant activity in the treatment of prostate cancer. (The formulas are shown in the description.).

Description

technical field [0001] The present invention relates to novel antagonist compounds of the androgen receptor; to methods of using such compounds in the treatment of diseases associated with the androgen receptor, such as prostate cancer; and to pharmaceutical combinations comprising these compounds. Background technique [0002] Androgen receptor (AR) is a ligand-dependent transcriptional regulatory protein that belongs to the nuclear receptor superfamily. Binding of the androgen receptor and an androgen, such as testosterone or, more effectively, dihydrotestosterone (DTH), results in a conformational change leading to activation of the androgen receptor. The activated androgen receptor binds to a specific DNA sequence in the nucleus of the target cell in the form of a dimer - the Androgen Response Element (ARE), regulates the expression of the target gene, and produces corresponding biological effects on cell proliferation, survival and differentiation. The androgen recepto...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D235/02C07D233/86C07D401/04A61K31/4184A61K31/4166A61K31/4439A61P35/00
CPCA61P35/00C07D233/86C07D235/02C07D401/04A61K31/4166A61K31/4184
Inventor 陈永恒徐广宇周文强
Owner CHANGSHA ZEDA MEDICAL TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products